Literature DB >> 31259366

Rubella Resurgence in Japan 2018-2019.

Mugen Ujiie1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31259366     DOI： 10.1093/jtm/taz047

Source DB:  PubMed          Journal:  J Travel Med        ISSN： 1195-1982            Impact factor:   8.490


× No keyword cloud information.
  5 in total

1.  Factors Predicting Rubella Vaccination and Antibody in Pregnant Women in Japan: A Report from Pregnant Women Health Initiative.

Authors:  Akiko Iwata; Kentaro Kurasawa; Kazumi Kubota; Mizuha Odagami; Shigeru Aoki; Mika Okuda; Etsuko Miyagi
Journal:  Vaccines (Basel)       Date:  2022-04-19

2.  Morbilliform drug eruptions caused by trimethoprim-sulfamethoxazole.

Authors:  Daisuke Takenaka; Toshinori Nishizawa
Journal:  BMJ Case Rep       Date:  2020-09-23

3.  A public health collaboration between medical professionals and Japan's professional football league for rubella awareness.

Authors:  Toshinori Nishizawa; Yuko Murashima; Yuichi Nakamura; Keigo Sugisawa; Hironobu Nishiori; Kengo Nakamura; Noriyuki Amano; Gautam A Deshpande; Hiroko Arioka
Journal:  J Gen Fam Med       Date:  2020-10-20

4.  Rubella Eradication: Not Yet Accomplished, but Entirely Feasible.

Authors:  Stanley A Plotkin
Journal:  J Infect Dis       Date:  2021-09-30       Impact factor: 5.226

5.  Conjunctivitis, the key clinical characteristic of adult rubella in Japan during two large outbreaks, 2012-2013 and 2018-2019.

Authors:  Hidetoshi Nomoto; Masahiro Ishikane; Takato Nakamoto; Masayuki Ohta; Shinichiro Morioka; Kei Yamamoto; Satoshi Kutsuna; Shunsuke Tezuka; Junwa Kunimatsu; Norio Ohmagari
Journal:  PLoS One       Date:  2020-04-24       Impact factor: 3.752
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.